Target intelligence / Profile preview

Host gut metabolic milieu

Molecular classification
Other, Biological System, Metabolome
01

Overview

The host gut metabolic milieu refers to the complex and dynamic chemical environment within the gastrointestinal tract, comprising host-derived molecules, dietary components, and microbial metabolites (Nicholson et al., 2012). This milieu plays a critical role in maintaining systemic homeostasis by influencing immune responses, energy metabolism, and signaling pathways across various organs, including the liver and brain (Koh et al., 2016). Alterations in this environment, often characterized by dysbiosis or shifts in metabolite profiles like short-chain fatty acids and bile acids, are linked to numerous pathologies such as inflammatory bowel disease, metabolic syndrome, and even neurodegenerative disorders (Fan & Pedersen, 2021). While not a single molecular target, the gut metabolic milieu is increasingly viewed as a therapeutic landscape where interventions like probiotics, prebiotics, and postbiotics aim to restore a healthy balance. Understanding the interactions within this milieu is essential for developing precision medicine approaches that leverage the gut-microbiome-host axis.

Other names
Gut metabolomeIntestinal metabolic environmentGut microbiota-derived metabolitesIntestinal milieuGut microbiota-host metabolic axis
02

Mechanism of action

Modulation of the microbial composition and metabolite profile to restore homeostatic signaling and reduce systemic inflammation (Nicholson et al., 2012; Fan & Pedersen, 2021).

03

Biological functions

MetabolismImmune responseSignal transductionHomeostasisNutrient absorption
04

Disease associations

Inflammatory bowel diseaseObesityType 2 diabetesMetabolic syndromeColorectal cancerNeurodegenerative disease
05

Safety considerations

Risk of systemic infection from live biotherapeuticsInduction of gut dysbiosisMetabolic shifts leading to weight gain or lossTransfer of antibiotic resistance genes (Koh et al., 2016).
06

Interacting drugs

Rifaximin

5 more in the full profile.

07

Biomarkers

Short-chain fatty acids (SCFAs)Secondary bile acidsTrimethylamine N-oxide (TMAO)Alpha diversity indexCalprotectin

Beyond the preview

Go deeper on Host gut metabolic milieu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host gut metabolic milieu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call